Suguru Kadomoto

17PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 24, 2026
Prognostic Value of a Novel Risk Score Combining Psoas Muscle Density and ALBI Grade in Localized Renal Cell Carcinoma.

|Aug 31, 2026
Comparative Prognostic Impact of Two-Dimensional and Three-Dimensional Computed Tomography-Based Sarcopenia Indices in Metastatic Castration-Sensitive Prostate Cancer.

|Aug 25, 2026
Stage-Specific Temporal Trends in Treatment Patterns and Overall Survival in Prostate Cancer: A Multicentre Real-World Cohort Study From KAMU-ON.

|Dec 30, 2025
Dynamic Changes in Albumin and Systemic Immune-Inflammation Index as Prognostic Markers in Patients Treated with Cabozantinib After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

Rikushi Fujimura, Hiroshi Yaegashi, Ryunosuke Nakagawa

|Jul 23, 2025
Androgen Receptor-Controlled microRNA-124-3p.2 Suppresses Prostate Cancer Progression via CCL2 Inhibition.

Shuhei Aoyama, Kouji Izumi, Kaoru Hiratsuka

|Jan 18, 2025
Comparison of the efficacy of enfortumab vedotin and paclitaxel plus carboplatin in patients with metastatic urothelial carcinoma.

Ryunosuke Nakagawa, Kouji Izumi, Ren Toriumi

Pageof 3

Frequent Collaborators

15 joint publications

Kouji Izumi

13 joint publications

Hiroaki Iwamoto

12 joint publications

Atsushi Mizokami

11 joint publications

Tomoyuki Makino